Advancing university research to the global marketplace
Our research programs make the university a leading force of innovation and change – locally, nationally and globally. With a long-term, comprehensive focus on commercialization, the university has built a robust set of resources to take promising discoveries from concept to market.
Brilliant faculty from 15 colleges and other units around the university are the driving force for nearly 400 invention disclosures each year. This translates into nearly 300 active licenses – technologies invented at Ohio State that are impacting lives around the world.
Our Partners And Resources
Our technology commercialization team is the bridge between research and the market. Ohio State innovators are continually making groundbreaking discoveries in fields that impact the human condition: medicine, manufacturing, logistics, international business, science and technology. Whether licensing a new technology to an existing enterprise or engaging with an Ohio State startup, our team is here to facilitate that process.
The Path to Commercialization
Our team works with hundreds of companies each year – companies ready to take the university’s innovations to market and impact lives. To illustrate our process, we have established a clear commercialization pathway for licensing a university technology.
Licensing Templates
To help get started, below find our standard templates for licensing a university technology. Please contact us to talk about next steps.
Contact Us
We’re here to help you. If you are interested in learning more or licensing a university technology, please contact a member of our team below.
Associate Director of Licensing
Arts and Sciences | Food, Agricultural and Environmental Sciences
Jason Dahlman, PhD, CLP
dahlman.3@osu.edu614-292-7945
Senior Intellectual Property and Grant Compliance Officer
John Cocumelli, JD
cocumelli.1@osu.edu614-688-3486
News
-
Learn more about Ohio State's risk management tool on 6/2
May 20, 2022
-
Drug developed by Ohio State Consortium shows promise in treating COVID-19 patients at high-risk for ARDS i...
April 21, 2022
The drug was partially developed by James Dalton during his time at Ohio State and the intellectual property exclusively licensed on a global basis by Veru is own...